BioLineRx Ltd. Adjustments For Reconcile Profit Loss
BioLineRx Ltd. (BLRX) reported Adjustments For Reconcile Profit Loss of -$6.05 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2026-03-23
| Period end | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 12 month |
|---|---|---|
| 2025-12-31 | -$6.05M 20-F · filed 2026-03-23 | |
| 2025-06-30 | -$3.96M 6-K · filed 2025-08-14 | |
| 2024-12-31 | -$34.65M 20-F · filed 2026-03-23 | |
| 2024-06-30 | -$25.23M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $38.01M 20-F · filed 2026-03-23 | |
| 2023-06-30 | $13.01M 6-K · filed 2024-08-15 | |
| 2022-12-31 | -$1.29M 20-F · filed 2025-03-31 | |
| 2022-06-30 | $498.00K 6-K · filed 2023-08-30 | |
| 2021-12-31 | $3.48M 20-F · filed 2024-03-26 | |
| 2021-06-30 | $3.98M 6-K · filed 2022-08-16 | |
| 2020-12-31 | $6.82M 20-F · filed 2023-03-22 | |
| 2020-06-30 | $1.11M 6-K · filed 2021-08-18 | |
| 2019-12-31 | $2.78M 20-F · filed 2022-03-16 | |
| 2019-06-30 | $573.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | -$1.23M 20-F · filed 2021-02-23 | |
| 2018-06-30 | -$2.05M 6-K · filed 2019-08-06 | |
| 2017-12-31 | $3.81M 20-F · filed 2020-03-12 | |
| 2017-06-30 | $1.75M 6-K · filed 2018-08-13 | |
| 2016-12-31 | $1.33M 20-F · filed 2019-03-28 | |
| 2015-12-31 | $232.00K 20-F · filed 2018-03-06 |